SCHEMBL3215543

SCHEMBL3215543

Cc1ccc(C#N)c(S(=O)(=O)n2cc(N3CCN4CCCC4C3)c3ncccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.40
ALDH1A1 P00352 1/20 0.37
ELANE P08246 2/20 0.37
ADCY5 O95622 1/20 0.37
HSD11B1 P28845 1/20 0.37
KLK7 P49862 1/20 0.36
CTSS P25774 2/20 0.36
KDM2B Q8NHM5 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SOS1 Q07889 2/20 0.35
DRD4 P21917 1/20 0.35
CXCR4 P61073 4/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965570 0.88 HTR6 (0.43) HTR6ALDH1A1ADCY5KDM2BMEN1
SCHEMBL3622911 0.81 HTR6 (0.47) HTR6ALDH1A1ELANEHSD11B1KLK7
SCHEMBL3216915 0.81 KDM2B (0.41) HTR6ADCY5CTSSKDM2B
SCHEMBL3207359 0.80 NPC1 (0.42) HTR6ALDH1A1ADCY5MEN1KMT2A
SCHEMBL3222945 0.80 HTR6 (0.43) HTR6ALDH1A1ADCY5MEN1KMT2A
SCHEMBL3218128 0.80 MET (0.43) HTR6ALDH1A1ADCY5CTSSMEN1
SCHEMBL3214560 0.79 HTR6 (0.50) HTR6ALDH1A1MEN1KMT2A
SCHEMBL3216934 0.77 HTR6 (0.43) HTR6ALDH1A1ADCY5MEN1KMT2A
SCHEMBL3215703 0.77 HTR6 (0.54) HTR6ALDH1A1
SCHEMBL3215142 0.76 HTR6 (0.39) HTR6ALDH1A1ADCY5KDM2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US claimed
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US disclosed
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US disclosed
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056531-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3B, HTR1B HTR6 1/4885ALDH1A1 897/4885ELANE 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.